Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP329846.RAVvb2L-esJyxaNrSeGUqgkHOGlwDxr-pHK9b5-SBUBS0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP329846.RAVvb2L-esJyxaNrSeGUqgkHOGlwDxr-pHK9b5-SBUBS0130_assertion type Assertion NP329846.RAVvb2L-esJyxaNrSeGUqgkHOGlwDxr-pHK9b5-SBUBS0130_head.
- NP329846.RAVvb2L-esJyxaNrSeGUqgkHOGlwDxr-pHK9b5-SBUBS0130_assertion description "[We resequenced TPH2 coding, 5' promoter, 3'-untranslated region, and splice junction regions in 190 individuals selected for ethnic and clinical diversity, determined haplotype structure using 15 single nucleotide polymorphisms spanning 106 kilobases (kb), and performed linkage analysis in 1798 cases and controls representing 4 populations (657 African Americans, including 104 suicide attempters and 135 with major depression; 513 Finnish whites, including 150 suicide attempters; 146 US whites, including 81 with depression, anxiety disorder, or both; and 482 southwestern American Indians, including 123 suicide attempters and 191 with depression, anxiety disorder, or both) and in 94 Finnish whites for cerebrospinal fluid 5-hydroxyindoleacetic acid levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP329846.RAVvb2L-esJyxaNrSeGUqgkHOGlwDxr-pHK9b5-SBUBS0130_provenance.
- NP329846.RAVvb2L-esJyxaNrSeGUqgkHOGlwDxr-pHK9b5-SBUBS0130_assertion evidence source_evidence_literature NP329846.RAVvb2L-esJyxaNrSeGUqgkHOGlwDxr-pHK9b5-SBUBS0130_provenance.
- NP329846.RAVvb2L-esJyxaNrSeGUqgkHOGlwDxr-pHK9b5-SBUBS0130_assertion SIO_000772 16203956 NP329846.RAVvb2L-esJyxaNrSeGUqgkHOGlwDxr-pHK9b5-SBUBS0130_provenance.
- NP329846.RAVvb2L-esJyxaNrSeGUqgkHOGlwDxr-pHK9b5-SBUBS0130_assertion wasDerivedFrom befree-20140225 NP329846.RAVvb2L-esJyxaNrSeGUqgkHOGlwDxr-pHK9b5-SBUBS0130_provenance.
- NP329846.RAVvb2L-esJyxaNrSeGUqgkHOGlwDxr-pHK9b5-SBUBS0130_assertion wasGeneratedBy ECO_0000203 NP329846.RAVvb2L-esJyxaNrSeGUqgkHOGlwDxr-pHK9b5-SBUBS0130_provenance.